Apple News In Conversation cover image

How new weight-loss drugs are changing conversations about obesity

Apple News In Conversation

00:00

Is Wigowi a Good Candidate for GLP1?

Wigowi is an obesity formulation of a GLP1 that was approved in the US. It's not for people who just want to lose a little bit of weight before their holiday or whatever. They're really supposed to be long-term treatments for the chronic disease of obesity, so not like a short-term fix for weight loss. This idea is exactly what many medical professionals are worried about.

Play episode from 13:48
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app